drugset / Trial / NCT05579223

Intrathecal Hydromorphone for Postoperative Pain of Anorectal Surgery

NCT05579223

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Anorectal problems, such as hemorrhoids, fistula, fissures, Etc., often require surgical treatment. Patients often have postoperative pain after these surgeries, which increases discomfort and hospital length of stay. The efficacy of oral non-opioids in the treatment of such pain is poor. Hydromorphone is an opioid analgesic commonly used orally or intravenously for postoperative pain management. We designed this trial to investigate the efficacy and safety of intrathecal (delivery directly to the spinal cord during spinal anesthesia) single dose hydromorphone versus intrathecal placebo in treating postoperative pain among human subjects after anorectal surgery, but also the recovery of postoperative motor capacity in these human subjects.

Timeline

Start
2022-10-17
Primary completion
2024-01-24
Completion
2024-01-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified 75 ug Intrathecal

Indications